Dispensary Opening Brings Expanded Access to Premium Products, Introduces New Brands and Delivers an Elevated Patient ExperienceNEW YORK and TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, has announced its expansion into St. Petersburg with the opening of its 25th GrowHealthy dispensary in Florida. The new St. Petersburg location ope ...

Core Insights - The U.S. cannabis industry is evolving with strong long-term growth expectations despite recent sector pullbacks, leading investors to seek companies with real revenue and disciplined expansion plans [1][2][20] Industry Overview - Legalization progress is expected to continue into 2026 and 2027, with state-level expansion and adult-use markets growing rapidly [2] - Large operators with broad footprints are benefiting from rising demand as many states have legalized recreational use [2] Company Highlights - **Trulieve Cannabis Corp. (TCNNF)**: - Holds a strong leadership position in Florida with over 190 dispensaries, focusing on medical patients and gradually expanding into other states [4][5] - Financially, Trulieve shows strong revenue performance and has improved profit margins through cost management and operational efficiency [7][8][9] - **Curaleaf Holdings, Inc. (CURLF)**: - One of the largest cannabis operators in the U.S. with over 140 dispensaries and a diversified product portfolio [10][11] - Continues to manage debt and strengthen its balance sheet while focusing on expense reductions and operational efficiency [13][14] - **Green Thumb Industries Inc. (GTBIF)**: - Operates over 90 stores with a focus on branded consumer products and product innovation [15][16] - Demonstrates impressive revenue growth and strong gross margins, maintaining a disciplined approach to expansion [18][19] Financial Performance - Trulieve has reported steady quarterly revenue during 2025, with a focus on debt reduction and cash flow improvements [7][9] - Curaleaf remains a top revenue producer but faces profitability challenges, emphasizing margin improvements [13][14] - Green Thumb has shown consistent quarterly revenue increases and strong financial profiles, making it an attractive long-term investment [18][19]

Core Insights - The cannabis sector is attracting investor interest due to growth opportunities despite market volatility, with marijuana penny stocks showing potential for significant upside as conditions improve [1][2] Industry Overview - The cannabis industry is adapting to changing consumer demands, competitive state markets, and evolving regulations, with a focus on financial discipline and strategic progress [2] - State-level expansion continues to support gradual industry growth, even amidst uncertainty regarding federal reform [2] Company Highlights - **Glass House Brands Inc. (GLASF)**: Focuses on large-scale greenhouse cultivation and retail operations in California, emphasizing cost reduction and brand recognition through strategic acquisitions and new store openings [4][7] - **Ascend Wellness Holdings, Inc. (AAWH)**: Operates across multiple states with a diverse product range, balancing pricing pressures and opportunities through geographic diversification and improved customer experiences [8] - **Planet 13 Holdings Inc. (PLNH)**: Known for its experience-based retail model, particularly in Las Vegas, and is expanding into new states while focusing on branded consumer products and operational efficiency [10][12] Financial Performance - **Glass House Brands**: Revenue growth driven by increased production and improved gross margins, with a positive trend in operating income as the company scales production [7] - **Ascend Wellness Holdings**: Revenue growth supported by wholesale and retail expansion, though still facing net losses due to debt and operating expenses; improving margins indicate operational progress [8] - **Planet 13 Holdings**: Modest revenue growth from store expansion, facing pressure on gross profit margins due to operating expenses, but showing progress in reducing overhead costs [12]

Core Viewpoint - MediPharm Labs Corp. is preparing for its Annual and Special Meeting of Shareholders on June 16, 2025, emphasizing the importance of shareholder support for its Board of Directors and strategic direction amidst a challenge from a dissident shareholder [1][2][6]. Financial Performance - In 2024, MediPharm reported a 27% year-over-year increase in net revenue and improved gross profit margin from 18% in 2023 to 31% [5]. - The company's Adjusted EBITDA loss narrowed by $8.3 million to $1.9 million in 2024 compared to the previous year, with expectations of reaching positive Adjusted EBITDA soon [5]. Strategic Developments - MediPharm has undergone a strategic revitalization, including the acquisition of VIVO Cannabis in March 2023, which has opened new international markets and contributed approximately $10 million in annual revenue from its Beacon brand in Australia [12][13]. - The company has streamlined operations, focusing on strategic business lines and reducing operating expenses by half through synergies from the VIVO acquisition [11][13]. Governance and Shareholder Engagement - The Board of Directors recommends shareholders vote using the GREEN proxy to support its nominees, highlighting concerns about the qualifications of dissident nominees from Apollo Technology Capital Corp. [2][6][16]. - MediPharm emphasizes its commitment to good governance practices, including an independent Chair and key committees, to enhance shareholder value [20][21]. Market Position and Future Outlook - MediPharm's product mix includes various cannabis products, with international sales exceeding 50% of revenues in recent quarters, positioning the company for growth in the medical cannabis sector [15]. - The company believes it has established a solid foundation for future growth and is committed to ongoing enhancements in governance and operational strategies [28][27].

Core Insights - iAnthus Capital Holdings, Inc. has expanded its operations by opening its 24th GrowHealthy dispensary in Fort Myers, Florida, enhancing patient access to premium cannabis products [1][4] - The new dispensary features an expanded lineup of brands, including The Vault, Sunshine State, and MPX, providing patients with greater choice and quality [2][3] - The company emphasizes a flower-first philosophy and community connection, aiming to meet diverse wellness needs through a comprehensive product menu [3][4] Company Overview - iAnthus is a vertically integrated cannabis company focused on building premium brands through cultivation, production, and retail operations across the United States [5] - The company is backed by a leadership team with expertise in cultivation, operations, and capital markets, leveraging acquisition-driven growth for competitive advantage [5] - iAnthus' brand portfolio includes MPX, Anthologie, Black Label, Cheetah, Frūtful, Last Resort, Moodz, Sunshine State, and The Vault [5]

Core Insights - Ayurcann Holdings Corp. has reported strong financial and operational results for the fiscal year ended June 30, 2025, highlighting its growth and market position in the Canadian cannabis industry [1][5]. Financial Highlights - Gross revenue reached CAD 55,446,352 for the fiscal year 2025, an increase from CAD 45,265,235 in 2024, reflecting a significant year-over-year growth [8]. - Adjusted EBITDA improved to CAD 507,570, compared to a loss of CAD 352,492 in FY2024, indicating a turnaround in financial performance [8]. Operational Highlights - The product portfolio has expanded to 80 SKUs nationwide, demonstrating the company's commitment to innovation and product diversity [8][9]. - Ayurcann's products are available in over 75% of licensed retail cannabis stores across Canada, showcasing a robust national distribution network [3]. - In Ontario, the largest cannabis market in Canada, Ayurcann has achieved over 80% retail penetration, with products in more than 1,500 licensed stores [4]. Market Position - Ayurcann has maintained a 100% year-over-year sales growth for the past three fiscal years (2021-2024), underscoring its operational strength and market leadership [2]. - The company has established strong relationships with the Ontario Cannabis Store and retail partners, enabling it to capture significant market share [4]. Corporate Update - Ayurcann will voluntarily delist from the OTCQB effective October 30, 2025, while continuing to trade on the Canadian Securities Exchange under the ticker symbol "AYUR" [10].

Industry Overview - The Canadian cannabis sector is gaining investor attention as the U.S. market approaches broader reform, with the U.S. cannabis market projected to reach approximately $38.5 billion in 2024 and grow at a CAGR of 11-12% through the late 2020s [1][3] - Legislative changes in the U.S., such as Delaware's adult-use cannabis sales starting August 1, 2025, and potential federal rescheduling of marijuana, are creating strong thematic tailwinds for Canadian cannabis stocks with U.S. exposure [1][3] Company Highlights Tilray Brands (TLRY) - Tilray has established a strong global identity by combining cannabis, wellness, and beverages, significantly expanding its U.S. footprint through acquisitions [4][6] - The company reported record revenue exceeding $820 million for fiscal 2025, with gross margins averaging around 40%, showcasing strong cost management [8][9] - Tilray's strategic pivot into hemp-based beverages and wellness products allows it to build a presence in the U.S. market despite federal restrictions [10][7] Canopy Growth Corporation (CGC) - Canopy Growth is recognized as a leading cannabis company in Canada, with ambitions to enter the U.S. market through strategic partnerships and acquisitions, notably its option to acquire Acreage Holdings [10][12] - The company generated nearly $300 million in revenue but reported a net loss exceeding $650 million, highlighting ongoing profitability challenges [14][15] - Canopy's U.S. strategy is designed to unlock value upon legalization, with a strong brand portfolio and rights to Acreage Holdings representing potential growth [16] Village Farms International (VFF) - Village Farms operates in both agriculture and cannabis, leveraging its expertise in greenhouse cultivation to strengthen its cannabis operations in Canada [18][19] - The company reported net income above $25 million in 2025, with adjusted EBITDA reaching nearly 30% of total sales, demonstrating strong profitability and revenue growth [20] - Village Farms' focus on cultivation efficiency and vertical integration has allowed it to achieve profitability, distinguishing it from many cannabis peers [20][21] Conclusion - Tilray, Canopy Growth, and Village Farms each demonstrate unique strategies for growth and financial improvement in the evolving cannabis landscape [21] - These companies are well-positioned to capitalize on potential U.S. legalization and changing market dynamics, offering various investment opportunities [21]

Industry Overview - The U.S. cannabis market is projected to exceed $50 billion annually within the next decade, indicating strong long-term growth potential [1] - Federal reform discussions and state-level legalization are driving investor interest in leading multi-state operators [1] Company Profiles Trulieve Cannabis Corp. (TCNNF) - Trulieve is one of the largest U.S. cannabis operators, with over 190 dispensaries nationwide, including more than 130 in Florida, giving it a dominant market share [3][5] - The company has expanded into states like Arizona, Pennsylvania, and Georgia, maintaining fully integrated operations across its markets [5] - In the most recent quarter, Trulieve reported revenue of approximately $298 million, with gross profit margins exceeding 50% and adjusted EBITDA around $80 million [6][8] Curaleaf Holdings Inc. (CURLF) - Curaleaf is the largest U.S. cannabis company by revenue, operating about 150 dispensaries, primarily in Florida, Arizona, and Massachusetts [9][11] - The company has a diverse product portfolio and is expanding internationally, particularly in Europe, which adds to its growth potential [11] - Curaleaf generated approximately $342 million in revenue in its latest quarter, with gross margins above 45% and adjusted EBITDA near $80 million [12][13] Cresco Labs Inc. (CRLBF) - Cresco Labs focuses on wholesale distribution and operates over 60 dispensaries, primarily in Illinois, Pennsylvania, Ohio, and Massachusetts [14][16] - The company is one of the largest branded cannabis product distributors in the U.S., ensuring consistent product quality through its integrated operations [16] - In its most recent quarter, Cresco reported revenue of approximately $194 million, with gross margins over 45% and adjusted EBITDA around $45 million [17][18] Market Dynamics - The U.S. cannabis industry is characterized by opportunities and challenges, with federal reform being a key catalyst for growth [19] - Competition, pricing pressures, and regulatory complexities necessitate disciplined management and operational efficiency among cannabis operators [19] - Trulieve, Curaleaf, and Cresco have demonstrated the scale and adaptability needed to navigate the current market environment [20]

Industry Overview - The U.S. cannabis industry is projected to surpass $44 billion in total sales by 2025, driven by adult-use markets in over 20 states and increasing demand for cannabis wellness products [1] - The industry supports hundreds of thousands of jobs, and despite federal delays, state-level progress continues to drive momentum [1] - Market sentiment fluctuates with cannabis reform discussions, creating both opportunities and uncertainty for traders [2] Company Highlights - AYR Wellness Inc. operates over 90 dispensaries across several major U.S. markets, focusing on premium cannabis brands and in-house product manufacturing [5] - Green Thumb Industries Inc. operates in 15 states with over 140 dispensary licenses, known for its consistent execution and financial discipline [9] - Verano Holdings Corp. operates over 135 dispensaries and emphasizes quality control and sustainable practices, with a strong presence in Florida [13] Financial Performance - AYR Wellness reported Q1 2025 revenue of $114.4 million, a 3% year-over-year increase, with an adjusted EBITDA margin of 23% [8] - Green Thumb Industries reported Q1 2025 revenue of $254.1 million, a 5.4% increase from the previous year, achieving a net income of $11.1 million [10][12] - Verano Holdings reported Q1 2025 revenue of $237 million, with an adjusted EBITDA margin of 28% and a net loss of $9.2 million, an improvement from the previous quarter [15] Investment Opportunities - Traders are focusing on technical analysis to identify potential breakouts in marijuana stocks, with key support and resistance levels being tested [2][3] - AYR Wellness, Green Thumb Industries, and Verano Holdings are highlighted as top stocks to watch for potential gains in the second half of 2025 [16]

Core Insights - iAnthus Capital Holdings, Inc. has opened its 22nd GrowHealthy dispensary in Palm Harbor, Florida, enhancing patient access to premium medical cannabis products [1][2] - The new dispensary aims to provide a modern retail experience focused on patient needs, featuring a variety of products including flower, vapes, and concentrates [2][3] - The grand opening aligns with iAnthus' strategy to expand its footprint in Florida's cannabis market while emphasizing high-quality genetics and whole-plant wellness [3][5] Company Overview - iAnthus is a vertically integrated cannabis company focused on building premium brands through cultivation, production, and retail operations across the United States [5] - The company leverages acquisition-driven growth and access to capital to create a long-term competitive advantage [5] - iAnthus' brand portfolio includes MPX, Anthologie, Black Label, Cheetah, Frūtful, Last Resort, Moodz, and Sunshine State [5]